Purdue Hits 2 Generics Makers With OxyContin Patent Suits
According to the suits, Epic Pharma LLC and Impax Laboratories Inc.’s abbreviated new drug applications for generic oxycodone hydrochloride extended-release tablets, covering various dosage strengths between 10 and 80 milligrams, infringe three patents covering high-purity OxyContin.
“The acts of infringement by [the companies] will cause plaintiffs irreparable harm for which they have no adequate remedy at law, and...
Already a subscriber? Click here to login